Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 81 ~ 100 of 25572, Page 5 of 1280
81. Is There a Seasonal Influence on Cognition and Dementia?
This Medical News article discusses a recently discovered association between time of year and cognitive performance even in people with Alzheimer disease.
10/24/2018 JAMA. Medical News & Perspectives by Jennifer Abbasi
82. Satisfaction in science
Nature''s survey offers a snapshot of salaries and career paths in the scientific sector.
10/24/2018 Nature: Career Feature by Chris Woolston
83. China hides identities of top scientific recruits amidst growing US scrutiny
Chinese researchers fear that affiliation with the high-status Thousand Talents scheme could make them targets of FBI investigations.
10/24/2018 Nature News by Smriti Mallapaty
84. AAOS Statement on Opioid Legislation Becoming Law
Washington, DC American Association of Orthopaedic Surgeons (AAOS) President David A. Halsey, MD, released the following statement after the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (H.R. 6) was signed into law by the president. The bipartisan agreement will help combat the public health crisis, which resulted in more than 72,000 drug-overdose deaths in 2017.
10/24/2018 American Academy of Orthopaedic Surgeons
85. American Academy of Orthopaedic Surgeons announces the launch of its Shoulder and Elbow Registry
Mission to improve orthopaedic care through the collection, analysis, and reporting of actionable data
10/24/2018 American Academy of Orthopaedic Surgeons
86. International Innovators in Medical and Surgical Eye Health to Convene in Chicago to Advance Patient Care
Thousands of eye physicians and surgeons this week will convene in Chicago to attend AAO 2018, the American Academy of Ophthalmology’s 122nd annual meeting.
10/24/2018 American Academy of Ophthalmology
87. Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS
This randomized trial compares the effects of low vs intermediate tidal volumes on ventilator-free days and mortality among intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS).
10/24/2018 JAMA. Published online October 24, 2018. doi:10.1001/jama.2018.14280
88. 6 ways fast-evolving pay models are affecting physician practices
AMA-RAND report: Doctors see opportunity for new payment models to improve care, but are overwhelmed by their complexity and the pace of change.
10/24/2018 American Medical Association (AMA) News by Andis Robeznieks
89. First analysis of ''pre-registered'' studies shows sharp rise in null findings
Logging hypotheses and protocols before performing research seems to work as intended: to reduce publication bias for positive results.
10/24/2018 Nature News by Matthew Warren
90. Leading cancer research charity takes tough stance on bullying
Cancer Research UK will be able to revoke grants if researchers and institutions do not abide by its new behaviour policy.
10/24/2018 Nature News by Holly Else
91. HH Pope Francis and WHO Director-General: Health is a right and not a privilege
The Director-General of WHO, Dr Tedros Adhanom Ghebreyesus, has met with His Holiness Pope Francis to discuss ways to ensure that all people can obtain the healthcare they need, whoever they are, wherever they live.
10/23/2018 World Health Organization (WHO)
92. Medtronic Receives FDA Approval for Valiant Navion(TM) Thoracic Stent Graft System
(GLOBE NEWSWIRE via COMTEX) --Next-Generation Thoracic Endovascular Repair (TEVAR) Device Expands Applicability to Broader Range of Patients
10/23/2018 Medtronic
93. 3 keys to giving physicians more face time with patients
Learn about a team-based primary care model that cuts patient wait times, gives doctors more time delivering care and raises job satisfaction.
10/23/2018 American Medical Association (AMA) News by Sara Berg
94. Small practice, less doctor burnout? 4 reasons that may be
Autonomy, deeper patient relationships among the reasons physicians at small offices may report less burnout.
10/23/2018 American Medical Association (AMA) News by Tanya Albert Henry
95. European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy in Melanoma
Opinion Granted Based on Significant Recurrence-Free Survival Benefit Demonstrated with KEYTRUDA in Pivotal Phase 3 EORTC1325/KEYNOTE-054 Trial Marks First Positive CHMP Opinion for KEYTRUDA in an Adjuvant Setting
10/22/2018 MERCK
96. Merck"s KEYTRUDA (pembrolizumab) Significantly Improved Overall Survival Compared to Standard of Care, as Monotherapy and in Combination with Chemotherapy, as First-Line Treatment for Patients with Recurrent or Metastatic Head and Neck Cancer
Survival Benefit Observed with KEYTRUDA Monotherapy in Patients Whose Tumors Expressed PD-L1 with CPS≥20 and CPS≥1 and in Total Patient Population for KEYTRUDA in Combination with Chemotherapy KEYTRUDA is the First Anti-PD-1 Therapy to Demonstrate a Survival Benefit as First-Line Therapy for Head and Neck Cancer that has Recurred or Metastasized Results from Pivotal Phase 3 KEYNOTE-048 Trial Presented Today at the ESMO 2018 Congress during the Presidential Symposium
10/22/2018 MERCK
97. Effect of Protocolized Weaning With Early Extubation to Noninvasive Ventilation vs Invasive Weaning on Time to Liberation From Mechanical Ventilation Among Patients With Respiratory Failure
This randomized trial compares the effects of protocolized weaning via early extubation to noninvasive ventilation vs standard weaning from invasive ventilation on time to liberation from mechanical ventilation among adults with respiratory failure ready to wean but with an unsuccessful spontaneous breathing trial.
10/22/2018 JAMA. Published online October 22, 2018. doi:10.1001/jama.2018.13763
98. British universities set up European outposts as Brexit looms
Establishing partner institutions in Europe might allow UK researchers to keep full access to EU funds.
10/22/2018 Nature News by Quirin Schiermeier
99. When fathers exercise, their future offspring may benefit, mouse study suggests
This exercising mouse is helping itself and its offspring, a new study suggests.
10/22/2018 Science: Health by Mitch Leslie
100. SOLO-1 Phase 3 Trial Demonstrates LYNPARZA® (olaparib) Maintenance Therapy Cut the Risk of Disease Progression or Death by 70 Percent in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Cancer
60 Percent of Patients Receiving LYNPARZA Remained Progression-Free at Three Years Compared to 27 Percent on Placebo Following Platinum-Based Chemotherapy YNPARZA Is the Only PARP Inhibitor to Demonstrate an Improvement in Progression-Free Survival in First-Line Maintenance Treatment for Newly-Diagnosed, Advanced Ovarian Cancer
10/21/2018 MERCK
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱